● Recruiting

Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode

Condition: Suicidal Ideation · Major Depressive Episode · Sponsor: Centre Hospitalier Universitaire de Nīmes

PhasePhase 3

Planned participants180

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

This study aims at investigating if adjunctive buprenorphine at low dose to treatment as usual is effective in reducing severe suicidal ideas in major depressive episode, and at determining the most effective dose.

This description comes directly from the study's public registry record.

Talk to the study team

Fabrice Jollant, MD · +33(0)1 45 65 85 72 · fabrice.jollant@parisdescartes.fr

Always discuss trial participation with your own doctor first.

Locations (9)

Ch Perrens	Bordeaux, France, France	Not Yet Recruiting
CHU Bicêtre	Le Kremlin-Bicêtre, France	Recruiting
Hospices Civils de Lyon	Lyon, France	Recruiting
CAPPA Jacques PREVERT	Nantes, France	Recruiting
CHU Nîmes	Nîmes, France	Recruiting
CH Sainte-Anne	Paris, France	Recruiting
CH Henri Laborit	Poitiers, France	Recruiting
Chu Toulouse Hopital Purpan	Toulouse, France	Not Yet Recruiting
CHU de Tours	Tours, France	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03646058